A multicentre, randomized phase 3 study on the optimization of the combination of bevacizumab with mFOLFOX/OXXEL in patients with metastatic colorectal cancer (mCRC)

Authors :: F. Perrone
Salvatore Tafuto
Mauro Piccirillo
Guglielmo Nasti
Paolo Delrio
Domenico Bilancia
A. Cassata
Secondo Lastoria
Alfredo Budillon
Lucrezia Silvestro
Alessandro Ottaiano
A. De Stefano
E. Di Gennaro
G. Rosati
Chiara Carlomagno
A. Avallone
Ciro Gallo
Francesco Izzo
Carmela Romano
F. Bianco
Source :: Annals of Oncology. 28:v173-v174
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Oncology
medicine.medical_specialty
Bevacizumab
business.industry
Colorectal cancer
Phases of clinical research
Hematology
medicine.disease
Internal medicine
medicine
In patient
business
medicine.drug

Full Text Access

Tools